Mexico Clears $12B Nestle-Pfizer Deal After Divestiture

Law360, New York (April 15, 2013, 5:06 PM EDT) -- Mexico's antitrust agency has reached a deal with Nestle SA allowing it to sell Pfizer Inc.'s Mexican infant formula business to a third party, removing one of the last roadblocks in the way of Nestle finalizing its $11.85 billion acquisition of Pfizer's global infant nutrition unit, the watchdog announced Monday.

According to the Federal Competition Commission, or CFC, its five-member board voted unanimously to allow Nestle to sell Pfizer’s Mexican unit to a third party, as well as giving an exclusive license to that company to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.